328 related articles for article (PubMed ID: 19062044)
1. Inhibition of tissue factor-factor VIIa proteolytic activity blunts hepatic metastasis in colorectal cancer.
Zerbib P; Grimonprez A; Corseaux D; Mouquet F; Nunes B; Petersen LC; Susen S; Ung A; Hebbar M; Pruvot FR; Chambon JP; Jude B
J Surg Res; 2009 May; 153(2):239-45. PubMed ID: 19062044
[TBL] [Abstract][Full Text] [Related]
2. Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study.
Petersen LC; Nørby PL; Branner S; Sørensen BB; Elm T; Stennicke HR; Persson E; Bjørn SE
Thromb Res; 2005; 116(1):75-85. PubMed ID: 15850611
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38.
Ott I; Weigand B; Michl R; Seitz I; Sabbari-Erfani N; Neumann FJ; Schömig A
Circulation; 2005 Jan; 111(3):349-55. PubMed ID: 15642762
[TBL] [Abstract][Full Text] [Related]
4. Extrahepatic synthesis of coagulation factor VII by colorectal cancer cells promotes tumor invasion and metastasis.
Tang JQ; Fan Q; Wu WH; Jia ZC; Li H; Yang YM; Liu YC; Wan YL
Chin Med J (Engl); 2010 Dec; 123(24):3559-65. PubMed ID: 22166631
[TBL] [Abstract][Full Text] [Related]
5. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
[TBL] [Abstract][Full Text] [Related]
6. Formation of tissue factor-factor VIIa-factor Xa complex prevents apoptosis in human breast cancer cells.
Jiang X; Guo YL; Bromberg ME
Thromb Haemost; 2006 Aug; 96(2):196-201. PubMed ID: 16894464
[TBL] [Abstract][Full Text] [Related]
7. [Study of the effect of TF/FVIIa complex on the expression of u-PAR mRNA in human ovarian cancer].
Fang J; Wei WN; Xia LH; Song SJ
Zhonghua Xue Ye Xue Za Zhi; 2004 Mar; 25(3):143-6. PubMed ID: 15182581
[TBL] [Abstract][Full Text] [Related]
8. The effects of activated factor VII in a cell-based model for tissue factor-initiated coagulation.
Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Hedner U; Roberts HR
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S21-5. PubMed ID: 9819025
[TBL] [Abstract][Full Text] [Related]
9. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
10. Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor.
Sørensen BB; Rao LV
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S67-71. PubMed ID: 9819031
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice.
Weijer S; Schoenmakers SH; Florquin S; Levi M; Vlasuk GP; Rote WE; Reitsma PH; Spek CA; van der Poll T
J Infect Dis; 2004 Jun; 189(12):2308-17. PubMed ID: 15181580
[TBL] [Abstract][Full Text] [Related]
12. [The effects of tissue factor/activated factor VII complex on the invasion and metastasis of human ovarian cancer].
Fang J; Wei WN; Xia LH; Song SJ
Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):523-7. PubMed ID: 15569528
[TBL] [Abstract][Full Text] [Related]
13. Tumor recurrence after partial hepatectomy for liver metastases in rats: prevention by in vivo injection of irradiated cancer cells expressing GMCSF and IL-12.
Aussilhou B; Panis Y; Alves A; Nicco C; Klatzmann D
J Surg Res; 2008 Oct; 149(2):184-91. PubMed ID: 18499129
[TBL] [Abstract][Full Text] [Related]
14. Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia.
Rijneveld AW; Weijer S; Bresser P; Florquin S; Vlasuk GP; Rote WE; Spek CA; Reitsma PH; van der Zee JS; Levi M; van der Poll T
Crit Care Med; 2006 Jun; 34(6):1725-30. PubMed ID: 16625114
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of factor VIIa affect the interface between the protease domain and tissue factor.
Carlsson K; Persson E; Carlsson U; Svensson M
Biochem Biophys Res Commun; 2006 Oct; 349(3):1111-6. PubMed ID: 16970919
[TBL] [Abstract][Full Text] [Related]
16. Microarray studies of factor VIIa-activated cancer cells.
Petersen LC
Thromb Res; 2008; 122 Suppl 1():S11-3. PubMed ID: 18691491
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa.
Aberg M; Wickström M; Siegbahn A
Thromb Res; 2008; 122(2):191-202. PubMed ID: 18031796
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of Factor VIIa/tissue factor.
Shirk RA; Vlasuk GP
Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1895-900. PubMed ID: 17600222
[TBL] [Abstract][Full Text] [Related]
19. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism.
Hembrough TA; Swartz GM; Papathanassiu A; Vlasuk GP; Rote WE; Green SJ; Pribluda VS
Cancer Res; 2003 Jun; 63(11):2997-3000. PubMed ID: 12782609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
